Pharmacokinetics, Pharmacodynamics (PK/PD) of Antibiotics: A Reality Check

  • 7,796

    Total Downloads

  • 37k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

The relationship between drug exposure and treatment effect of antibiotics has been studied since the 1980s. Indeed, PK/PD is considered superior to empirical dose response clinical trials for the selection of a dosing regimen for pivotal clinical efficacy trials. In addition, PK/PD analyses and PoP PK modeling is now integrated into both antibiotic drug approval and breakpoint determination. However, recent comprehensive analyses of phase 3 clinical data have failed to demonstrate a relationship between PK/PD and clinical or microbiological outcomes, including mortality.

Through an integrated review of published data, both preclinical and clinical, an effort will be made to explain why there is a disconnect between the PK/PD parameters of antibiotics and their validation in the clinical trial setting, including both randomized clinical trials and retrospective cohort analyses.

The Topic Editors welcome submissions related but not limited to the following areas:

1. PK/PD principles derived from in vitro and in vivo preclinical studies. Focus is on antibiotics of any antibiotic class used to treat gram-negative bacillary infections. It is expected that much of the information will be for beta-lactam antibiotics. Data to include in vitro static (AST, time-kill) and dynamic (chemostat, hollow fiber) models and in vivo animal infection models (dose fractionation and humanized drug exposure.
2. PK/PD analyses from clinical studies human subjects and patients. Individual papers could review single drugs or drug classes that provide evidence of PK correlations with clinical and microbiologic outcomes. Both positive or negative (or inconclusive) outcomes should be included.
3. Assessment of published data where PK/PD principles did not work as expected and understanding possible reasons for the lack of correlation between PK/PD parameters and clinical outcomes in clinical studies. Could include sensitivity of MIC determination to the lack of subtherapeutic drug exposure.
4. Implications of the lack of validation of PK/PD principles in clinical studies. Are PK/PD principles wrong or are studies involving patients too complex? Are clinical and microbiological endpoints including mortality insensitive (or inadequately insensitive) to treatment effect? If PK/PD parameters are not valid in a clinical setting, what role is there for therapeutic drug monitoring (TDM)?
5. Assess the validity of MIC determination and its critical importance in PK/PD analyses.
6. Assess the validity of clinical breakpoints, how they are determined and their validity in predicting outcomes. Discuss the clinical implications of not updating breakpoints as the changes based on new dosing regimens and PK/PD data.
7. Assessment of individualized dosing regimens especially in serious ill ICU patients, i.e. the benefit or lack for therapeutic drug monitoring (TDM). Also assess evidence that augmented renal clearance (ARC) impacts clinical outcomes.
8. Is the immune system really only “background noise” or are there other problems by neglecting it in in-vitro PK/PD models or by using neutropenic mice?

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.